August Summary: What We Know So Far About Covid-19 Antibody Tests

August Summary: What We Know So Far About Covid-19 Antibody Tests

Organizations and governments around the world are using the WHO test-isolate-trace strategy to fight coronavirus disease 2019 (COVID-19). When it comes to testing, two types of tests are currently in use, viral, and antibody tests.  The viral or molecular test looks for coronavirus in a human body, while the antibody or serology test detects antibodies to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Up until the end of August, there have been developments in the design and development of the COVID-19 antibody tests. Many of these efforts made are focused on producing test kits with 100% sensitivity and specificity. Experts rely on the accuracy of the rapid COVID-19 antibody test kit to inform decisions and studies on the immune system.

The availability of the COVID-19 antibody tests has increased with some major society and agencies questioning the accuracy of SARS-CoV-2 serologic tests. Experts have pushed the adoption of best practice guidance to assist clinicians, clinical laboratories, patients, and policymakers in decision making. They aim to ensure the optimal use of COVID-19 antibody tests in a variety of settings.

Towards the end of August, diagnostic tests for COVID-19 antibodies are still used only for population surveys. Antibody testing is rarely used as a normal diagnostic test for SARS-CoV-2. However, it can be used when the PCR tests have failed or delayed. The serology test becomes useful when a patient shows all the symptoms of COVID-19 but still tests negative twice using diagnostic PCR assays.

On August 03, 2020, the U.S. Food and Drug Administration issued emergency use authorizations (EUAs) to two of Siemens’ “semi-quantitative” COVID-19 serology tests. These antibody tests can display an estimated quantity of antibodies in an individual’s blood sample. To date, the FDA has authorized 40 antibody tests under EUAs.

Thanks to covid-19 antibody tests, governments around the world have begun reopening their economies in stages.  They rely on serology testing to determine the level of Immunity in the community so that they can relax some restrictions and severe mitigation measures.

At the moment, health experts have not yet determined that the presence of antibodies confer the presence of immunity against reinfection. Some research made in Hong King and the US suggests that antibodies can protect humans against re-infection.

Since not all experts are on the same page about immunity against future infections, then more research is required. According to scientists, understanding the epidemiology of COVID-19 is not enough to fight the pandemic. Health experts find it more important to study the response system of the human body against SARS-CoV-2.

Experts believe that the golden rule of evaluating Covid-19 antibody tests is doing a performance study. During this study, diagnostic tests for covid-19 antibodies are done on individuals with a diverse mixture of responses.

Towards the end of August, seven African countries (Liberia, Sierra Leone, Zambia, Zimbabwe, Cameroon, Nigeria, and Morocco) committed to starting administering coronavirus antibody tests. According to the Africa Centres for Disease Control and Prevention, these countries are looking to understand the extent of the outbreak on the continent. At the same time, the South African Health Products Regulatory Authority (SAHPRA) authorized the use of one coronavirus antibody testing kit.

UK’s game-changer towards lifting the lockdown measures in the country is the rolling out of antibody tests. At the moment, these medical devices are available to frontline medical staff. The testing and monitoring program will see antibody tests being delivered first to care home residents and patients, and then later roll out at-home antibody tests to the wider public.

For a COVID-19 antibody test kit to be approved by the British Medicines and Healthcare products Regulatory Agency it should have an accuracy rate of 98 percent and above. The World Health Organization’s regulatory approval for the accuracy of serology test devices has a lower bar of 90 percent sensitivity and 97 percent specificity.

As August ended, COVID-19 antibody tests were still not approved as diagnostic tools for COVID-19. Besides monitoring and controlling the spread of the disease, antibody tests are being used in some nations to identify potential convalescent plasma donors. These are individuals that have fully recovered and tested positive for coronavirus antibodies, who are willing to donate a portion of their blood. The convalescent plasma is used to develop a special antibody treatment for patients who are seriously ill.

As scientists and manufacturers work tirelessly to develop 100% accurate, organizations and nations all over the world are getting reliable results from FDA EUA authorized rapid COVID-19 antibody test kits. Rapid Connect Medical is a Key distributor of innovative, productive, and affordable COVID-19 testing solutions.

You no longer have to spend too much of your valuable time sourcing for reliable coronavirus antibody test kits because Rapid Connect medical has you covered. For large orders and more information about their products, feel free to contact the company’s rapid-ship response team.

A range of affordable mass screening point-of-care tests are available on order from different authorized distributors such as Rapid Connect Medical. This company allows companies and investors to make bulk test kit orders through its rapid-ship response team. If you would like to get more information on the testing capability of their covid-19 antibody test kits, feel free to contact Rapid Connect Medical and place your order today.

The sampling done with the rapid COVID-19 antibody test kit cassette using lateral flow from Rapid Connect Medical will give you the IgG and IgM detectable diagnostics results from between two and ten minutes. It can be used for reference in combination with the results from an RT-PCR (reverse transcriptase-polymerase chain reaction) test. A single finger prick to draw blood can be used with our kit that detects antibodies.  This positive or negative result can be detected as soon as 3 days after exposure to COVID-19 (sometimes before the onset of symptoms occur).  Knowing if you have active igM antibodies even in the first week of infection can help get the best treatment for an infected person.

If you do test positive, potentially exposed, or have traveled to a region with high infection rates, you should seek care from your doctor for treatment and continue to test for IgG antibodies daily until you are cleared to leave quarantine. The sensitivity, specificity, and accuracy or our antibody test kit is very high.  This testing method for the public gives real time results and helps to identify initial infection before the severe flu like symptoms begin.  This kit is intended to be administered by a health care professionals and providers at a clinic or other health care facilities.  Many of the faulty test kits were removed from the FDA EUA website; all of our test kits are authorized by the FDA and their data appears and is included on that website.  Consumers can trust the validity and quality of the antibody test kits sold by Rapid Connect Medical.

The kits used for diagnostic tests for COVID-19 antibodies are usually designed for research use or qualitative detection of coronavirus, and not home use. Also, they can only be used to test the presence of IgG and IgM antibodies against SARS-CoV-2. Since they are aiding tools to RT-PCR or CT scanning, a clinical diagnosis of COVID-19 should be done by a healthcare professional or physician.

An antibody detection test cassette contains antigens from SARS-CoV-2 combined with gold nanoparticles. The device has two wells (one for specimen and one buffer) and a control region on the upper end.  Two types of antibodies are of great importance in diagnostic tests for COVID-19 antibodies: Immunoglobulin M (IgM) and Immunoglobulin G (IgG). 

The importance of the gold nanoparticles in the detection test cassette is to create a colored line in the control region.  Antigens targeting a specific antibody are located in their respective regions on the nitrocellulose membrane of the test cassette. The IgG and IgM regions are coated with anti-human antibodies for each. 

The rapid COVID-19 antibody test kits you will find on the market are designed to detect SARS-CoV-2-specific antibodies. The ones distributed by Rapid Connect Medical are FDA research approved and evaluated and validated by a comprehensive clinical study.  This antigen test kit was developed in response to the COVID-19 global pandemic and offers a power tool for health care providers.  The immune response produced by a Coronavirus viral infection is what this test measures.

The CDC testing standards for laboratories were strictly followed during the clinical trials for our antibody test kit.  This is a serology elisa based test for SARS-CoV-2 antibodies in serum or plasma components of blood. Information on the collection data, total sample size, and validation of lab samples can be found here for review.  Interpretations of test results should be confirmed with a lab and a a medical professional should diagnose your infection status not only on the sole basis of your rapid test kit results.  This rapidtest should be performed by a licensed medical professional and your infection status determination may require additional tests.  With the presence for IgG antibodies people can have immunity for some time.  While viruses such as influenza have been a problem in the past, Covid-19 is a serious problem we aim to help eliminate.

Rapid Connect Medical distributes large orders of Coronavirus (SARS-CoV-2) IgM/IgG rapid test kits to global professional sports league and arenas. Rapid Connect Medical is the leading provider of Covid-19 Antibody test kits in small quantities25 test kit packs, as well as bulk orders for large countries, companies, and organizations.  If your institute or corporation is in the need of antibody test kits, feel free to email our sales team.  The company covers the USA, Canada, South America, and European territories. Therefore, if you are from these areas, Rapid Connect Medical will be able to assist you with availability, pricing, and ordering. Our test kit is considered to be the best product on the market for rapid Covid-19 antibody testing.


Our test kits are FDA EUA (Emergency Use Authorization) Authorized, have the CE Declaration for authorized European Union distribution, and have an authorization for use by the HHS for Pharmacies and Pharmacists.  Federal guidance has been issues for Rapid Connect Medical’s COVID-19 Antibody test kit that is 98.20% accurate with results in 2 to 10 minutes.  Don’t take a risk using inferior test kits, our Antibody Test kits are tested in a biotechnology laboratory!

The development of the technology for this screening standard with confirmed scientific accuracy is unique to Rapid Connect Medical‘s Antibody Test Kit.  If you are interested in order a large quantity for commercial, biomedical, biological, science, or pharmaceutical applications and have questions, feel free to book a call with our sales team.  In response to the global demand, our manufacturers have the capacity to support your required production needs.  Covid-19 testing is also covered by many insurance plans.  For our update on insurance coverage from our website, that can be accessed here.  Our newest test kit also has data from specimens collected by the Mayo clinic.

Important Features:

Certification and Authorization – COVID-19 antibody test kits from Rapid Connect Medical are safe for use under the Emergency Use Authorization (EUA) of the FDA (Food and Drug Administration). They also are authorized by The U.S. Department of Health and Human Services (HHS) for Pharmacy or Pharmacist use. The antibody test kits come with a CE Declaration, meaning that they are clear for use in countries that fall under the European Union. 

Storage and Quality – the Coronavirus antibody testing kits from Rapid Connect Medical have a shelf life of 24 months from the date of manufacture. 

Ease of Use – the COVID-19 antibody test kits from Rapid Connect Medical are easy to use and you can get your results in two to ten minutes. The antibody test kits are designed for medical professional use and not as an over-the-counter product for home use. 

Technology – the rapid serologic COVID-19 antibody test kits from Rapid Connect Medical use lateral flow technology. 

We offer fast shipping methods for our antibody test kits at an affordable rate. You can order test kits online at https://rapidconnectmedical.com/

Be sure to follow us on Facebook, LinkedIn, YouTube, and Twitter for updates, news, and new product announcements.  We will also be having press events in the near future so keep an eye out for more news about Rapid Connect Medical!

Stop the Spread – Test Yourself Now

Leave a Reply

Your email address will not be published. Required fields are marked *

Translate »